M*Student¤Î¥á¥âÍÑ¥Ö¥í¥°
¥á¥â¤Ç¤¹¡¦¡¦¡¦¡£
²¼Î¡¤Ï¤Ä¤é¤¤¤â¤Î¤Ç¤¹
²ÆµÙ¤ß¤òÍøÍѤ·¤Æ¿ô½µ´Ö¥¿¥¤¤Ç¥Á¥ã¥ì¥ó¥¸¥ó¥°¤ÊÂںߤò¤·¤Æ¤¤¤¿23ºÐÃËÀ­¤¬ÀèÆüµ¢¹ñ¤¹¤ë¤âȯǮ¤È¿åÍÍÀ­¤Î²¼Î¡¤òÁʤ¨¤Æ¤¤¤ë¤ÈM*Student¤Ë¥á¡¼¥ë¤¬¤¢¤Ã¤¿¡£¤Þ¤¡¡¢¥Ò¥È¥´¥È¤Ê¤Î¤ÇÌÌÇòȾʬ¤ÇÊÖ»ö¤ò½ñ¤¤¤Æ¤ß¤¿¡£




²¼Î¡¤Ï¤Ä¤é¤¤¤â¤Î¤Ç¤¹¡£

°ìÅÙ¤À¤±Í§¿Í¤È²ÎÉñ´ìÄ®¤Î¾ÆÆù²°¤Ë¹Ô¤Ã¤¿ÍâÆü¤Ë¤Ò¤É¤¤²¼Î¡¤ËǺ¤Þ¤µ¤ì¤Þ¤·¤¿¡£Í§¿Í¤Ï¥Ô¥ó¥Ô¥ó¤·¤Æ¤¤¤¿¤Î¤Ç´¶À÷¾É¤äÈùÀ¸Êª¤Î¥È¥­¥·¥ó¤Ë¤è¤ë²¼Î¡¤È¤¤¤¦¤è¤ê¤Ï¿©¤Ùʪ¤Î»É·ã¡ÊÎ㤨¤Ð¥Ë¥ó¥Ë¥¯¤äÌý¡Ë¤Ë¤è¤ë¡¢¤Á¤ç¤Ã¤È¤·¤¿Ä²²áÉҤΤ褦¤Ê¾É¾õ¤À¤È»×¤Ã¤Æ¤¤¤Þ¤¹¡£ÆüËܿͤϤªÊ¢¤¬¥Ç¥ê¥±¡¼¥È¤Ê¤è¤¦¤À¤«¤é³¤³°¤Ç²¼Î¡¤·¤Æ¤â¤³¤Î¤è¤¦¤Ê¡É¿©¤¢¤¿¤ê¡É¤Ç¤¢¤ë¤³¤È¤â¿¤¤¤½¤¦¤Ç¤¹¡£Çö¤á¤¿¥Ý¥«¥ê¤Ë±ö¤ò°ì¤Ä¤Þ¤ß¤·¤Æ°û¤ó¤ÇÍò¤¬²á¤®¤ë¤Î¤òÂԤƤм£¤ê¤Þ¤¹¡£

³¤³°ÅϹҤΤ¢¤ë23ºÐÃËÀ­¤Î²¼Î¡¤Ï¤¿¤¤¤Æ¤¤¤Î¾ì¹ç¤¬ ETEC(enterotoxigenic E.coli)¤Ç¤¢¤ë¤³¤È¤¬Â¿¤¯¡¢´µ¼Ô¥µ¥¤¥É¤Î²ÁÃʹѤˤè¤Ã¤Æ¤ÏST¹çºÞ¤Þ¤¿¤Ï¥Ë¥å¡¼¥­¥Î¥í¥ó¤Ç¼£ÎŤȤʤë¤Ç¤·¤ç¤¦¡£ÅÓ¾å¹ñ¤Ç¤Ï ST ¹çºÞÂÑÀ­¶Ý¤¬¤ª¤ª¤¤¤Î¤ÇìÔÂô¤Ë¡Ö¥·¥×¥í¥Õ¥í¥­¥µ¥·¥ó500mg¡¡1Æü2²ó¤ò1¡Á3Æü´Ö¡×¤Î¥ì¥¸¥á¥ó¤Ê¤ó¤Æ¤É¤¦¤Ç¤·¤ç¤¦¡£¤â¤Á¤í¤óÇö¤á¤¿¥Ý¥«¥ê¤Ë±ö¤ò°ì¤Ä¤Þ¤ß¤ÇÍò¤¬²á¤®¤ë¤Î¤òÂԤäƤ¤¤Æ¤â¼£¤ê¤Þ¤¹¡£

Űú¤¯¾ì¹ç¤Ï¥¢¥á¡¼¥ÐÀÖΡ¡¢¥é¥ó¥Ö¥ëÊÜÌÓÃî´¶À÷¾É¤äι¹ÔÀèÆÃÍ­¤Î¥ì¥¢¤ÊÈùÀ¸Êª¤¬¸¶°ø¤«¤â¤·¤ì¤Þ¤»¤ó¡£
¤½¤ÎÃÏÆÃÍ­¤Î´¶À÷¾É¤Î¥Ç¡¼¥¿¤ÏCDC¤Îι¹Ô¼Ô¸þ¤±·ò¹¯¥µ¥¤¥È¡ØYellow Book¡Ù¤¬Ìò¤ËΩ¤Ä¤Ç¤·¤ç¤¦¡£
¤¿¤ÀȯǮ¤È²¼Î¡¤Ç¤¦¤Ê¤µ¤ì¤Æ¤¤¤ë23ºÐÃËÀ­¤Ë¤È¤Ã¤Æ¡ÖÌò¤ËΩ¤Ä¤Ç¤·¤ç¤¦¡×¤È¸À¤ï¤ì¤¿¤È¤³¤í¤Ç¡¢¡Ö¤½¤ó¤Ê¤³¤È¤è¤ê²¶¤Î²¼Î¡¤ò²¿¤È¤«¤·¤Æ¤¯¤ì¡ª¡×¤È¸À¤¤¤¿¤¤¤«¤â¤·¤ì¤Þ¤»¤ó¡¦¡¦¡¦¡£Çö¤á¤¿¥Ý¥«¥ê¤Ë±ö¤ò°ì¤Ä¤Þ¤ß¤ÇÍò¤¬¤Ê¤«¤Ê¤«²á¤®µî¤é¤Ê¤¤¤è¤¦¤Ê¤é¸å³Ø¤Î¤¿¤á¤ËÄ´¤Ù¤Æ¤ß¤Þ¤·¤ç¤¦¡£

¥Þ¥é¥ê¥¢Î®¹ÔÃÏÂÓ¤«¤é¤Îµ¢¹ñ¼Ô¤Ç¡ÖȯǮ¡Ü²¼Î¡¡×¤Î´ÕÊÌ¿ÇÃǤÏ
£±¤Ë¥Þ¥é¥ê¥¢£²¤Ë¥Þ¥é¥ê¥¢¡¢£³¡¤£´¤¬¤Ê¤¯¤Æ£µ¤Ë¥Þ¥é¥ê¥¢¡¢£¶¤Ë¤½¤Î¾¤È¸À¤ï¤ì¤Æ¤¤¤Þ¤¹¤¬
¥Þ¥é¥ê¥¢Î®¹ÔÃϰè¤Ë¤Ï­¤òƧ¤ßÆþ¤ì¤Æ¤¤¤Þ¤»¤ó¤«¡©
¤³¤Î¾ì¹ç¤Ï¤µ¤Ã¤µ¤È¡Ö»ä¤Ï¥Þ¥é¥ê¥¢¤«¤â¤·¤ì¤Þ¤»¤ó¡ª¡×¤È°å¼Ô¤ËÀèÆþ´Ñ¤òÍ¿¤¨¤Æ¸¡ºº¤ò¤·¤Æ¤â¤é¤ï¤Ê¤±¤ì¤ÐÃ×»àŪ¤Ê¤Î¤ÇÃí°Õ¤Ç¤¹¡£

¤È¤ê¤¢¤¨¤º¡¢é¥ÃߤÏÃÖ¤¤¤Æ¤ª¤¤¤Æ¡¢23ºÐÃËÀ­¤Î¥¦¥ó¥³¤òÇÝÍܤ·¤Æ¤ß¤¿¤¤¤«¤Ê¡£ ÇÝÃÏ¿¤¯¤Æ¥á¥ó¥É¡¼¤½¤¦¤À¤±¤É¡¦¡¦¡¦¡£

Reference
¡¦´¶À÷¾É³°Íè¤Î»ö·ïÊí
¡¦£Ã£Ä£Ã Travelar's Health

¤ÈÃúÇ«¤ËÊÖ¿®¤·¤Æ¤ª¤¤¤¿¡£¤·¤Ð¤é¤¯ÊÖ»ö¤¬Íè¤Ê¤¤¤«¤é¤¯¤¿¤Ð¤Ã¤¿¤«¤Ê¡©¤È»×¤Ã¤Æ¤¤¤¿¤éÍÈ¡¹¤È¡Ê¤Ç¤â¤Ê¤¤¤«....¡ËÊÖ»ö¤¬Í褿¡£




23ºÍÃËÀ­¤Ï¡¢»°½µ´Ö¤Û¤É¥¿¥¤¡¦¥é¥ª¥¹¤ËÂںߤ·¤Æ¤¤¤¿¤È¤Î¤³¤È¡£
ͺÂç¤Ê¥á¥³¥óÀî¤òÂΤǴ¶¤¸¤ë¤ó¤À¤È¡¢ÀîÍ·¤Ó¤ò¸½ÃϿͤȳڤ·¤ó¤Ç¤¤¤¿¤é¤·¤¤¡£
Àî¤Î¿§¤ÏÍÜʬ¤¿¤Ã¤×¤ê¤Î¤Þ¤ÃÃã¿§¡£¡£¡£
Ʊ¹Ô¤·¤Æ¤¤¤¿Ë¿»á¤Ë¤Ï

¥¢¥¸¥¢¤Îø¿å²ÏÀîÃæ¤ËÍ·½Ð¤·¤Æ¤¤¤ë¥»¥ë¥«¥ê¥¢¤¬·ÐÈé´¶À÷¤·¤Æ¤¤¤Æ¡¢4½µ¸å¤Ë¤Ï°­´¨ÀïØË¡¢¤½¤Î¸å¡¢ÄÙáç¡¢áíº¯¤òÀ¸¤¸¡¢Ê¢ÉôËÄËþ¤òÄ褷¤Ê¤¬¤é´Î¹ÅÊѤǻà¤Ì¤«¤é¡¢¤½¤ó»þ¤Ï¡¢½»·ìµÛÃî¾É/schistosomiasis¤Îµ®½Å¤Ê¤´¸¥ÂΤȤ·¤Æ£ËÂçÉÂÍý²ò˶¼¼¤Þ¤Ç¤´ÆÆ»Ö¤¯¤À¤µ¤ì¤Þ¤»m(_ _)m

¤È¶¼¤µ¤ì¤ë¡£¡£¡£

¿©¤Ùʪ¤Ï¡¢²¿¤ÎÆù¤À¤«¤ï¤«¤é¤Ê¤¤À֤ߤòÂÓ¤Ó¤¿Æù¤ä¤­¤å¤¦¤êÅù¤ÎÀ¸ÌîºÚ¡¢É¹¿å¡Ê??!!¥©¥£¥©¥£.....¡Ë¤Ê¤É´í¸±¤Ê¤â¤Î¤òµó¤²¤¿¤é¤­¤ê¤¬¤Ê¤¤¤Û¤É¡£

ËܿͤϵÞÀ­¤«ËýÀ­¤«¤òȽÃǤ¹¤Ù¤¯¤¸¤Ã¤ÈM*Student¤Ë¸À¤ï¤ì¤¿¤È¤ª¤êÇö¤á¤¿¥Ý¥«¥ê¡õ°ì¤Ä¤Þ¤ß¤Î±ö¤ÇÂн衣

Ç®¤Ïµ¢¹ñ¸å¤¹¤°¤Ë¤Ç¤¿¤¬¡¢1Æü¤Ç¤ª¤µ¤Þ¤Ã¤¿¡£¥Þ¥é¥ê¥¢±øÀ÷Ã϶è¤Ë¤Ï­¤òƧ¤ßÆþ¤ì¤Æ¤¤¤Ê¤¤¤È°Â¿´¤¹¤ë°ìÊýºÆÅÙ¡¢Ç®È¯¤¹¤ë¤«ËܿͤϤӤ¯¤Ó¤¯¤·¤Æ¤¤¤¿¤¬¤½¤Î¸åÇ®¤Ï¤Ê¤·¡£

º£Æü¤Ï¥È¥¤¥ìÆó²ó¤È½çÄ´¤Ê¤«¤ó¤¸¡£

¡¦¡¦¡¦¡¦¡¦¡¦¤Æ¤«É±¡¤¤¤Ã¤¿Êý¤¬¤¤¤¤¤Ã¤¹¤è¤Í¡£






¤Þ¤¡¡¢Â祸¥ç¥Ö¤ä¤í¡ª¡ª¡¢¡¢¡¢¤È»×¤¦²Æ¤Îͼ¤Ù¡£

¤½¤¦¤Ï¸À¤Ã¤Æ¤â¤­¤Ã¤È²¼Î¡¤ò¤·¤Æ¤¤¤ëËܿͤϤĤ餤¤Î¤Ç¤·¤ç¤¦¡£

¸æ»¡¤·¤·¤Þ¤¹¡£¤È¤ê¤¢¤¨¤º¥ï¥¿¥¯¥·Ìȵö»ý¤Ã¤Æ¤¤¤Ê¤¤¤Î¤Ç¥¢¡¼¥á¥ó*


blog¥é¥ó¥­¥ó¥°¡Ê°å³ØÉôÌç¡Ë¤Ë»²²ÃÃæ¡ª¡ª



IJÆâºÙ¶Ý²Ê¤È·ùµ¤À­¶Ý¤ò¥«¥Ð¡¼
µ¤¤Ë¤Ê¤Ã¤Æ¤¤¤¿Learning Issue¤Ë¤Ò¤È¤Þ¤º¥±¥ê¤ò¤Ä¤±¤Æ¤ª¤³¤¦¡£

­¡Enterobacteriacea¤Î¹¥µ¤À­GNB¡ÊE.coli, K.pneumonia¤Ê¤É¡Ë¡¢
­¢·ùµ¤À­¶Ý¡ÊB.fragilis¤Ê¤É¡Ë

¤ÎξÊý¤ò¥«¥Ð¡¼¤¹¤ë¹³¶ÝÌô¡£

¡Êa¡Ë·Ú¾É¤Î¤È¤­
¡¦cefmetazole¡¡1g¡ß4²ó/day
¡¦ampicillin-sulbactam¡¡1.5g¡ß4²ó/day

¡Êb¡Ë½Å¾É¤Î¤È¤­
¡¦imipenem-cilastatin¡¡0.5¡Á1g¡ß3¡Á4/day¡¢
¤¢¤ë¤¤¤Ï¡¢
¡¦meropenem¡¡1g¡ß3²ó/day

°Ê²¼¤ò²Ã¤¨¤Æ¤â¤è¤¤¡£
¡¦clindamycin¡¡600mg¡ß3¡Á4²ó/day
ÎÐÇ¿¶Ý¤Î´ØÍ¿¤¬¤¢¤ê¤¦¤ë¤Ê¤é¡¢gentamicin¤òÊ»ÍѤ¹¤ë
¡£

¡Ø½Å¾É¤Ç¼£ÎŤμºÇÔ¤¬µö¤µ¤ì¤Ê¤¤»þ¤³¤½¥«¥ë¥Ð¥Ú¥Í¥à¡ª¡ª¡Ù

ÉÂÅï¤Ç¤è¤¯¸«¤ë¥æ¥Ê¥·¥ó£Ó¡¢¡¢¼Â¤ÏBroad spectrum¤Ç¤¢¤ë¤È¤¤¤¦¤³¤È¤ò´Î¤ËÌ两ơ¢°Â°×¤Ê»ÈÍÑ¡¦ÍðÍѤÏÈò¤±¤¿¤¤¡£
¤È¤ê¤¢¤¨¤º¼«Ê¬¤ÎÃæ¤Ç¤³¤ó¤Ê¤È¤­¤Ï¥æ¥Ê¥·¥ó£Ó¡ª¤È¤¤¤¦´ð½à¤òÀߤ±¤Æ¤ª¤­¤¿¤¤¤È»×¤Ã¤¿¡£

¤È¤¤¤¦¤³¤È¤Ç¡¢

¡Ø¥æ¥Ê¥·¥ó£Ó¤Ï·ùµ¤À­¶Ý¤¬´ØÍ¿¤¹¤ë´¶À÷¾É¤ËÍѤ¤¤ë¡Ù

¤È¤¤¤¦¸ÀÍÕ¤ò³Ð¤¨¤Æ¤ª¤³¤¦¡£

¤¢¤Þ¤ê¤ËÉÂÅï¤Ç¥æ¥Ê¥·¥ó£Ó¤ò¸«¤Æ¤¤¤¿¤â¤Î¤À¤«¤é¤³¤¤¤Ä¤Î¼çÄ¥¤Ëµ¤¤¬¤Ä¤«¤Ê¤«¤Ã¤¿¡£Broad¤Ê¹³¶ÝÌô¤Ë¤âÀìÌçÀ­¤ò¤â¤¿¤»¤Æ¥¹¥Ú¥¯¥È¥é¥à¤ÎÃæ¤ÇÆÃ¤Ë¶¯¤¯µ±¤¤¤Æ¤¤¤ë¾ì½ê¤ò³Ð¤¨¤Æ¤ª¤¯¤³¤È¤¬Âç»ö¤À¡£carbapenem¤À¤Ã¤¿¤éGNB¤ÎÀìÌç¤À¤Èº£¤Ïǧ¼±¤·¤Æ¤¤¤ë¡£¤ä¤Ð¤¤GNB¤Î»þ¤ËÅо줷¤Æ¤â¤é¤¨¤Ð¤¤¤¤¤À¤í¤¦¡£

·ùµ¤À­¶Ý¤Ë¶¯¤¤¤Û¤«¤Î¦Â¥é¥¯¥¿¥àºÞ¤È¤·¤Æ¡¢ceftazidime¤äcarbapenem¤¬¤¢¤ë¤¬¡¢¤¤¤º¤ì¤âMRSAͶƳǽ¤¬¹â¤¤¡£°ìÊý¡¢ampicillin-sulbactam¤ÏMRSAͶƳǽ¤¬Ä㤤¤È¤µ¤ì¤ë¡£

̵Â̤ʻ¦À¸¡¦ÂÑÀ­¶Ý¤ÎͶƳ¤ÏÈò¤±¤¿¤¤¡ª
¤Þ¤¿P.aeruginosa¤ò¥«¥Ð¡¼¤·¤Æ¤·¤Þ¤¦¹³¶ÝÌô¤Î»ÈÍÑ¤Ë¤Ï°ì¸ÆµÛ¹Í¤¨¤Æ¤ß¤ëɬÍפ¬¤¢¤ë¤È»×¤¦¡£Pseudomonas¤ò̵Â̤ˤ¿¤¿¤¯¤È¸å¡¹¤Þ¤Ç¤·¤Ä¤³¤¯ÉÕ¤­Å»¤ï¤ì¤ëµ¤¤¬¤·¤Æ¤Ê¤é¤Ê¤¤¡£¿¨¤é¤Ì¿À¤Ë㮤ê̵¤·¤È¤¤¤¦´¶¤¸¤Ç¤¢¤í¤¦¤«¡£

Reference
¡¦´¶À÷¾É¥ì¥¸¥Æ¥ó¥È¥Þ¥Ë¥å¥¢¥ë



blog¥é¥ó¥­¥ó¥°¡Ê°å³ØÉôÌç¡Ë¤Ë»²²ÃÃæ¡ª¡ª


ÆüËܤˤÏÅÀÅ©ÍѤÎMetronidazole¤¬¤Ê¤¤¡ª
¤Ü¤ó¤ä¤ê¤ÈÀ¸¤­¤Æ¤¤¤Æ¤â¿Í¤ÈÏäò¤¹¤ë¤È²¿¤«¤Èȯ¸«¤¬¤¢¤ë¤â¤Î¤Ç¤¢¤ë¡£
ÀèÆüºÙ¶Ý¸¡ºº¼¼¤ËÍ·¤Ó¤Ë¹Ô¤Ã¤¿»þ¡¢³«Ê¢¼ê½Ñ¸å¤Î±¦Ä²¹üãݥɥ졼¥ó¤«¤é¤Î¤È¤Ã¤Æ¤â½­¤¤ÇӱդΣÇÀ÷¤ò¤ä¤é¤»¤Æ¤¤¤¿¤À¤¤¤¿¡£

¤È¤Ë¤«¤¯½­¤¤¡£¾¯¤·»À¤Ã¤Ñ¤¤¤è¤¦¤ÊÆ÷¤¤¤¬¤¹¤ë¤Ç¤·¤ç¤Èµ»»Õ¤µ¤ó¤Ë¸À¤ï¤ì¤¿¤¬¤½¤³¤Þ¤ÇÆ÷¤¤¤ò¶ãÌ£¤¹¤ëͦµ¤¤¬»ä¤Ë¤Ï¤Ê¤«¤Ã¤¿¡£
À÷¤á¤ëÁ°¤«¤é·ùµ¤À­¶Ý¤ÎÆ÷¤¤¤òȯ¤·¤Æ¤¤¤¿¸¡ÂΤÀ¡£

À÷¤á¤Æ¤ß¤ë¤ÈÂç¾®¤µ¤Þ¤¶¤Þ¤ÊGPC¤ÈB.fragilis¤é¤·¤­GNB¤¬¤¤¤Æ¤Û¤Ü´Ö°ã¤¤¤Ê¤¯·ùµ¤À­¶Ý¤Ë¤è¤ë´¶À÷¡ÊÊ¢¹ÐÆâÇ¿áç¡Ë¤À¤È¶µ¤¨¤Æ¤¤¤¿¤À¤¤¤¿¡£

½Ñ¸å¤Ê¤Î¤Ç·Ð¸ý¤ÏÈò¤±¤Æ¹³¶ÝÌô¤Ï²¿¤ò»È¤¨¤Ð¤è¤¤¤Î¤«¤È¹Í¤¨¤¿»þ¡¢

­¡·ùµ¤À­¶Ý¤ò¼ç¤ËÁÀ¤Ã¤¿¹³¶ÝÌô
­¢¹¥µ¤À­GNB¤È·ùµ¤À­¶Ý¤òÁÀ¤Ã¤¿¹³¶ÝÌô

¤É¤Á¤é¤¬¤¤¤¤¤Î¤«¤Ê¤¡¡¢¤È¹Í¤¨¤¿¡£
¤ª¤½¤é¤¯´µ¼Ô¤µ¤ó¤Î½Å¾É´¶¤¬¶¯¤¤¾ì¹ç¤Ï¼ºÇÔ¤¬µö¤µ¤ì¤Ê¤¤¤Î¤Ç­¢¤ò¹Í¤¨¤Æ¥«¥ë¥Ð¥Ú¥Í¥à¤Ç¤â¤è¤¤¤Î¤À¤í¤¦¤«¡©¥«¥ë¥Ð¥Ú¥Í¥à¤Ï²¹Â¸¤·¤È¤¯¤È¤¹¤ë¤È¥»¥Õ¥¡¥Þ¥¤¥·¥ó·Ï¡©¡Ê¤Ç¤âB.flagilis¤ÎÂÑÀ­¤¬¿´ÇÛ¡¦¡¦¡¦¡Ë¡¢Metronidazole+Quinolone?¡¢ Piperacillin-tazobactam?¡Ê¤³¤ì¤«¤Ê¤ê¥Ö¥í¡¼¥É¡¦¡¦Ç®É¤ǤÏAmpicillin-sulbactam¤ÈÊÂÎó¤Ç1st choice¡Ë
´Ö°ã¤Ã¤Æ¤Ï¤¤¤Ê¤½¤¦¤À¤¬¤Ê¤ó¤«¥Ñ¥Ã¤È¤·¤Ê¤¤¡£Ê¢¹ÐÆâ´¶À÷¾É¤ÏÆñ¤·¤¤....¡ÊLearning Issue¡Ë

­¡¤Î·ùµ¤À­¶Ý¤ò¤Í¤é¤Ã¤¿¾ì¹ç¤Ï²£³ÖËì¤è¤ê²¼¤Î·ùµ¤À­¶Ý¤ÇB.fragilis¤Ë¤Á¤ã¤ó¤È¸ú¤¤¤Æ¤¯¤ì¤ë¹³¶ÝÌô¤Ï¤È¹Í¤¨¤ë¤ÈMetronidazole¤¬É⤫¤Ö¡£
¤Ç¡¢µ»»Õ¤µ¤ó¤ÈÏ䷤Ƥ¤¤¿¤é¡¢Clindamycin¤Ç¤·¤ç¤¦¤È¸À¤¦¡£

¤Ï¤Æ¡©¤Ê¤¼¤À¤í¤¦¡©¤È»×¤Ã¤¿¡£

¤È¤¤¤¦¤Î¤â¶áǯClindamycinÂÑÀ­¤ÎB.fragilis¤¬Áý¤¨¤Æ¤­¤Æ¤¤¤ë¤é¤·¤¤¤«¤é¡¢B.flagilis¤Ë¤Û¤È¤ó¤ÉÂÑÀ­¤ò¤ß¤é¤ì¤Ê¤¤Metrinidazole¤ÎÊý¤¬Empric Therapy¤È¤·¤Æ¤Ï¤¤¤¤¤Î¤Ç¤Ï¤Ê¤¤¤«¤È¹Í¤¨¤¿¤ï¤±¤À¡£

¤Ï¤Æ¤Ï¤Æ¡©¡©¤È¹Í¤¨¤Æ¤Õ¤È»×¤¤¤Ä¤¤¤¿¡£

¡Ø¤Ò¤ç¤Ã¤È¤·¤ÆÆüËܤˤÏÅÀÅ©ÍѤÎMetronidazole¤¬¤Ê¤¤¤Î¤Ç¤¹¤«¡©¡Ù

¤Ê¤ë¤Û¤É¡¢¡¢¡£¤½¤¦¤¤¤¦¤³¤È¤À¤Ã¤¿¤Î¤«¡¦¡¦¡¦¡£

¤¦¤Á¤ÎÂç³ØÉ±¡¤Ç¤ÏClindamycinÂÑÀ­¤ÎB.fragilis¤Ï¤Þ¤À¤Û¤È¤ó¤É¤¤¤Ê¤¤¤é¤·¤¤¤«¤é¡¢²£³ÖËì¤è¤ê²¼¤Î·ùµ¤À­¶Ý¤ËClindamycin¤Ç¤âOK¤È¤¤¤¦¤³¤È¤Ç¤¹¤¬¡¢ClindamycinÂÑÀ­¤ÎB.fragilis¤¬¥¦¥è¥¦¥è¤¤¤ëɱ¡¤Ç¤Ï¤É¤¦¤¹¤ë¤Î¤Ç¤·¤ç¤¦¡£Empiric¤Ë¤Ï¥«¥ë¥Ð¥Ú¥Í¥à¤È¤¤¤¦ÁªÂò»è¤Ë¤Ê¤ë¤Î¤«Èݤ«¡©¤½¤ì¤À¤Ã¤¿¤é­¡¤â­¢¤â´Ø·¸¤Ê¤¤¤Ê¤¡¤È»×¤Ã¤¿¤ê¤â¤·¤¿¡£

¤½¤·¤ÆÆâ¤ÎÂç³ØÉ±¡¤ÇClindamycinÂÑÀ­¤ÎB.fragilis¤¬¤Û¤È¤ó¤É¤¤¤Ê¤¤Íýͳ¤ÏClindamycin¤ò»È¤¦ÀèÀ¸¤¬¤Û¤È¤ó¤É¤¤¤Ê¤¯¤Æ¥Ï¥Ê¤«¤é¥«¥ë¥Ð¥Ú¥Í¥à£±¤Ã¥Ý¥ó¡¢´¶¼õÀ­¸¡ºº¸å¤Ë¤âDe-escalation¤ò¤·¤Ê¤¤¤«¤é¤Ê¤Î¤«¤Ê¤¡¡©¤È¤â»×¤Ã¤¿¡£

¤µ¤ÆÏäϤ«¤ï¤Ã¤Æ¡¢¡ØÆüËܤˤÏÅÀÅ©ÍѤÎMetronidazole¤¬¤Ê¤¤¡Ù¤È¤¤¤¦¸ÀÍդθºß¤ò»ä¤Ï¼Â¤ÏÃΤäƤ¤¤¿¡£´äÅÄÀèÀ¸¤Î¡Ø´¶À÷¾É³°Íè¤Î»ö·ïÊí¡Ù¤Î¥³¥é¥à¤Ç

¡Ø·Ð¸ýÀݼè¤Î¤Ç¤­¤Ê¤¤¤ª¤Ð¤¢¤Á¤ã¤ó¤Îµ¶ËìÀ­Ä²±ê¡£¶ìÆù¤Îºö¤È¤·¤Æ1Æü3²óMetronidazole¤Îçµ¾û¤ò»ÈÍѤ·¤Æ¼£ÎŤ·¤¿¤ê¤¹¤ë¡£çµ¾û1Æü3²ó¤Ê¤ó¤ÆÇϼ¯¤Ê¼£ÎŤ¬¹Ô¤ï¤ì¤Æ¤¤¤ë¤Î¤Ï¡¢À¤³¦¤Ò¤í¤·¤È¤¤¤¨¤É¤âÆüËܤÀ¤±¤Ç¤¢¤ë¡£¡Ù

¤È¤¤¤¦¥·¥ç¥Ã¥­¥ó¥°¤Êµ­»ö¤òÆÉ¤ó¤À¤³¤È¤¬¤¢¤Ã¤¿¤«¤é¤Ç¤¢¤ë¡£

Ãμ±¤È¤·¤Æ¤Ï¡ÉÃΤäƤ¤¤¿¡É¤Î¤À¤¬¡¢¼ÂºÝ¤Ë¼«Ê¬¤Ç¹³¶ÝÌô¤Ï²¿¤¬¤¤¤¤¤«¤Ê¤È¹Í¤¨¤Æ¡¢Metronidazole¤«¤Ê¡©¤È¹Í¤¨¤¿·ë²Ì¡¢¡ØÅÀÅ©ÍѤÎMetronidazole¤¬¤Ê¤¤¡ª¡Ù¤È¤¤¤¦»ö¼Â¤òÌܤÎÅö¤¿¤ê¤Ë¤¹¤ë¤È¶¯Îõ¤Ë°õ¾Ý¤Ë»Ä¤ë¤â¤Î¤Ç¤¢¤ë¡£

Reference
¡¦¹³¶ÝÌô¤Î¹Í¤¨Êý¡¢»È¤¤Êý
¡¦´¶À÷¾É³°Íè¤Î»ö·ïÊí



¿Íµ¤blog¥é¥ó¥­¥ó¥°¤Ø
Sister Joseph nodule
¤È¤¢¤ë¥»¥ß¥Ê¡¼¤ÎÈÖ³°ÊÔCase Study¤Î»þ¤Ë½Ð¤Æ¤­¤¿ËµçÁ¥ê¥ó¥ÑÀá¤Î¼ðı¡£¤³¤ì¤Ë¤Ï¡ØSister Joseph nodule¡Ù¤È¤¤¤¦¤«¤Ã¤³¤¤¤¤Ì¾Á°¤¬¤Ä¤¤¤Æ¤¤¤ë¡£

Sister Joseph¥ê¥ó¥ÑÀá¤Î¼ðı¤ÏÊ¢¹ÐÆâ¡¦¹üÈ×Æâ°­À­¼ðáç¡¢Lymphoma¤Î¸ºß¤ò¶¯¤¯µ¿¤ï¤»¤ë¡£¤³¤ì¤¬¤¢¤ë¤È¤Û¤Ü°­À­¼À´µ¤¬±£¤µ¤ì¤Æ¤¤¤ë¤È¤â¸À¤ï¤ì¤Æ¤¤¤ë¡Ê¤é¤·¤¤¡Ë¡£

Ëö´ü¤ÎÊ¢¹ÐÆâ¡¦¹üÈ×Æâ°­À­¼ðáç¡¢Lymphoma¤Ç¤Ï¿¤¯¤Î´µ¼Ô¤µ¤ó¤Ç¿¨¤ì¤ë¤³¤È¤¬¤Ç¤­¤ë¤«¤â¤·¤ì¤Ê¤¤¡£¼Â½¬¤ÎºÝ¤ËÊ¢¤ò¿¨¿Ç¤·¤Æ¡ÖSister Joseph nodule¤ò¿¨¤ì¤Þ¤¹¤Í¡×¤È»ØÆ³°å¤Ë¸À¤Ã¤Æ¤ß¤¿¤«¤Ã¤¿¡£

º£¤Þ¤Ç¥ê¥ó¥ÑÀá¤ÏƬ·ÛÉô¡¢º¿¹ü¾åãÝ¡¢æþãÝ¡¢ÉªãÝ¡¢Áͷ¡¦ÂçÂÜÉô¤Î£µ¤Ä¡Ê¤Á¤Ê¤ß¤Ë¤³¤Î¤¦¤ÁÎ¥¤ì¤¿£²¥ö°Ê¾å¤Î¥ê¥ó¥ÑÀá¼ðı¤¬¤¢¤ë¤ÈÁ´¿ÈÀ­¥ê¥ó¥ÑÀá¼ðı¡¨Generalized Lymphadenopathy¤È¤¤¤¦¡Ë¤·¤«ÃΤé¤Ê¤«¤Ã¤¿¤¬¡¢Ê¢¤Ç¤â¿¨¤ì¤ë¤³¤È¤¬¤¢¤ë¤Î¤À¤ÈÊÙ¶¯¤Ë¤Ê¤Ã¤¿¡£¤·¤«¤â¤«¤Ê¤êSpecific¤À¡£

¤Á¤Ê¤ß¤ËSister Joseph nodule¤ÎͳÍè¤ÏMayo Clinic¤òÁÏÀߤ·¤¿°ì¿Í¤Ç¤¢¤ë³°²Ê°åWilliam J.Mayo¤Î½õ¼ê¤ò¤·¤Æ¤¤¤¿¥Ê¡¼¥¹¤¬³«Ê¢¤¹¤ëÁ°¤Î¾ÃÆÇ¤Î»þ¤Ëȯ¸«¤·¤¿¤³¤È¤«¤é̿̾¤µ¤ì¤¿¤ÈMayo Clin Proc¤ÎLymphadenopathy¤ÎReview¤Ë½ñ¤¤¤Æ¤¢¤Ã¤¿¡£¤Á¤Ê¤ß¤Ë¤³¤ÎÁíÀâ¤Ç¤ÏSister Mary Joseph nodule¤Î¡ÉMary¡É¤ÏÀµ¤·¤¯¤Ê¤¤¤ó¤¸¤ã¤Ê¤¤¤«¤È½ñ¤¤¤Æ¤¢¤ë¡£°ìÊý¡¢NEJM¤ÎImages in Clinical Medicine¤Ç¤ÏSister Mary Joseph¡Çs Nodule¤È¤¤¤¦Ì¾Á°¤Ç¾Ò²ð¤µ¤ì¤Æ¤¤¤Æ¤³¤Î¥Ê¡¼¥¹¤Î̾Á°¤¬Sister Mary Joseph (1856-1939)¤Ç¤¢¤Ã¤¿¤³¤È¤«¤é̿̾¤µ¤ì¤¿¤Èµ­¤µ¤ì¤Æ¤¤¤ë¡£

¤Þ¤¡¡¢¤É¤Ã¤Á¤Ç¤â¤¤¤¤¤ó¤À¤±¤Éµ¤¤Ë¤Ê¤Ã¤¿¤ï¤±¤À¡£Mayo Clin Proc¤¬¡ÉMary¡É¤ÏÀµ¤·¤¯¤Ê¤¤¤ó¤¸¤ã¤Ê¤¤¤«¤È½ñ¤¤¤Æ¤¤¤ë¤Î¤À¤«¤é¤È¤ê¤¢¤¨¤º¤³¤Ã¤Á¤òºÎÍѤ·¤Æ¤ª¤³¤¦¡£

¤É¤¦¤¦¤Ç¤â¤¤¤¤¤Ä¤¤¤Ç¤Ë¤â¤¦°ì¤Ä¡£
¿Ç»¡¥¨¥Ã¥»¥ó¥·¥ã¥ë¥º¤ÎLymphadenopathy¤Î¾Ï¤Ë½ñ¤¤¤Æ¤¢¤ëTieneyÀèÀ¸¤ÎPearl

Pain in an enlargrd lymph node after alcohol use means Hodgkin's disease until proven otherwise.

¤Î¸µ¥Í¥¿¡Ê¡©¡ËÏÀʸ¤¬Mayo Clin Proc¤ÎReference¤Ë¤¢¤²¤é¤ì¤Æ¤¤¤¿¡£Íߤ·¤¤¡¦¡¦¡¦¡£¿Þ½ñ´Û¤Ë¹Ô¤±¤Ð¸¡º÷¤Ç¤­¤ë¤«¤Ê¡©

Cavalli F. Rare syndromes in Hodgkin¡Çs disease.
Ann Oncol.1998;9(suppl 5):S109-S113.

¤Á¤Ê¤ß¤ËËÁƬ¤ÎCase¤Ï40ºÐÂå½÷À­¤Î»ÒµÜðô´â¤Ç¤¢¤Ã¤¿¡£

Reference
¿Ç»¡¥¨¥Ã¥»¥ó¥·¥ã¥ë¥º¡½¾É¾õ¤ò¤ß¤ë´í¸±¤Ê¥µ¥¤¥ó¤ò¤è¤à
Lymphadenopathy Mayo Clin Proc 2000;75:723.
Sister Mary Joseph¡Çs Nodule N Engl J Med 2005;352:1913


¿Íµ¤blog¥é¥ó¥­¥ó¥°¤Ø
ÆüËܤÏÇßÆÇ¼£ÎŤˤª¤¤¤Æ¸å¿Ê¹ñ
´äÅÄ·òÂÀϺÀèÀ¸¤Î¡Ø´¶À÷¾É³°Íè¤Î»ö·ïÊí¡Ù¤òÆÉ¤ó¤Ç¤¤¤¿¤éÌÌÇò¤¤µ­½Ò¤¬¤¢¤Ã¤¿¡£

ÇßÆÇ¤Î¼£ÎŤȤ¤¤¨¤Ð¥Ù¥ó¥¶¥·¥ó¡¦¥Ú¥Ë¥·¥ê¥ó¤Î°ì²ó¶ÚÃí¤Ç¾¡É餢¤ê¡ª¤Ç¤¢¤ë¡£¡Ê¤¿¤À¤·ÆüËܤˤϤ³¤ÎÁÇÀ²¤é¤·¤¤Ìô¤¬¤Ê¤¤¡Ë¡¢¤È¡£

¤½¤·¤ÆÃí¤ËÌÌÇò¤¤µ­½Ò¤¬

¡ÖºÇ¶á¤Ç¤Ï¡¢¥Ù¥ó¥¶¥·¥ó¡¦¥Ú¥Ë¥·¥ê¥ó¤Î¤Ê¤¤¸å¿Ê¹ñ¤Î¤¿¤á¤Ë¥¢¥¸¥¹¥í¥Þ¥¤¥·¥ó£±²óÅêÍ¿¡Ê2£ç·Ð¸ý¡Ë¤¬¡¢½é´ü¤ÎÇßÆÇ¤äearly latent syphilis¤Ë¸ú²Ì¤¬¤¢¤ë¡¢¤È¤¤¤¦¥Ç¡¼¥¿¤¬½Ð¤Æ¤¤¤ë¡£¤³¤ÎÏÀʸ¤¬ÆüËܤòÈéÆù¤Ã¤¿¤â¤Î¤Ê¤Î¤«¤É¤¦¤«¡¢É®¼Ô¤Ï²Éʹ¤Ë¤·¤ÆÃΤé¤Ê¤¤¡×

´äÅÄÀèÀ¸¤Î´é¤¬É⤫¤ó¤Ç¤¯¤ë¡£

¤È¤¢¤ë´¶À÷¾É¤Î¥»¥ß¥Ê¡¼¤Ç¤â´äÅÄÀèÀ¸¤Ï¤³¤ÎÏäò¤·¤Æ¤¤¤¿¤Î¤ÇÆüËܤδ¶À÷¾É¿ÇÎŤθå¿Ê¹ñ¶ñ¹ç¤òÙèÙ餹¤ë¤«¤Ê¤ê¥Í¥¿Åª¤ÊÏÀʸ¤Ê¤Î¤À¤í¤¦¡£

»ö¼Â¡¢´¶À÷¾É¤ÎÊÙ¶¯¤ò¤·¤Æ¤¤¤ë¤ÈÆüËܤδ¶À÷¾É¿ÇÎŤˤª¤±¤ëÊݸ±Å¬±þ¤¬¤É¤¦¤âÏÀÍýŪ¤Ç¤Ï¤Ê¤¤¤â¤Î¤¬Â¿¡¹¤¢¤ë¤³¤È¤Ëµ¤¤Å¤¯¡£¡Êµ¶ËìÀ­Ä²±ê¤Ë¥Ð¥ó¥³¥Þ¥¤¥·¥ó¤Ê¤É¡ËÊݸ±Å¬±þ¤À¤±¤Ç¤Ê¤¯ÌµÂ̤ÊÌô¤Ï¿¤¤¤Î¤ËɬÍפʹ³¶ÝÌô¤½¤Î¤â¤Î¤¬¤Ê¤«¤Ã¤¿¤ê¡Ê¥»¥Õ¥¡¥í¥¹¥Ý¥ê¥ó¤Î¼ïÎà¤Î¿¤µ¡¦¡¦¡¦¡£¥Ê¥Õ¥·¥ê¥ó¡¦¥ª¥­¥µ¥·¥ê¥ó¤¬¤Ê¤¤¡ª¡Ë¤Ç¤È¤Ë¤«¤¯°­¤¤°ÕÌ£¤Ç¤Î¡Ö¥Æ¥­¥È¡¼¡×¤È¤¤¤¦¸ÀÍÕ¤¬¤Ô¤Ã¤¿¤ê¤Ç¤¢¤ë¡£¤½¤ì¤È¤â¡Ö¥Æ¥­¥È¡¼¡×¤òÁõ¤Ã¤¿¡ÖÌþÃå¡×¤¬Â¸ºß¤¹¤ë¤Î¤«¤â¤·¤ì¤Ê¤¤¡£¤½¤·¤Æ¤¢¤Þ¤ê´¶À÷¾É¤ÎÊÙ¶¯¤ò¤·¤¿¤³¤È¤¬¤Ê¤¤Í§¿Í¤ÈÏä·¤¿¤ê¼Â½¬¤Ç¥á¥í¥Ú¥ó¤òÇٱ꼣ÎŤËÂФ·¤¤¤Æ¤ª¤â¤à¤í¤Ë½èÊý¤·¤Æ¤¤¤ë°å»Õ¤Ë¼ÁÌä¤ò¤·¤¿¤ê¤¹¤ë¤ÈÌÀ¤é¤«¤ËÏ䬺¬ËÜŪ¤Ë¤«¤ß¹ç¤ï¤Ê¤¯¤Æ¥¤¥é¥Ä¥­¤¹¤é´¶¤¸¤ë¡£¤Ê¤ó¤È¤«¤Ê¤é¤Ê¤¤¤Î¤«¡¦¡¦¡¦¡£¡Ê¢«»ä¼«¿È¤Î¤³¤È¤Ç¤¢¤ë....¡Ë¤¿¤ÀÀÄÌÚÀèÀ¸¡¢´äÅÄÀèÀ¸¡¢¸ÞÌ£ÀèÀ¸¡¢ÂçÌîÀèÀ¸¤Î¿ÔÎϤΤª¤«¤²¤Ç¼ã¼ê¤òÃæ¿´¤ËÎɤ¯¤Ï¤Ê¤Ã¤Æ¤­¤Æ¤¤¤ëµ¤¤Ï¤¹¤ë¤¬¡£¤¿¤Þ¤Ë²¿¤¬Àµ¤·¤¤¤Î¤«¤ï¤«¤é¤Ê¤¯¤Ê¤ë¡£¤¿¤À¤³¤ì¤é¤ÎÀèÀ¸¤ÎÏäϤ¤¤Ä¤â²Ê³ØÅª¤Ç¤¢¤ê¡¢¥Ý¥ê¥·¡¼¤¬¤¢¤Ã¤ÆÊÙ¶¯¤ò¤¹¤ë¿È¤È¤·¤Æ¤Ï¤È¤Æ¤âÆ´¤ì¤ë¤·¡¢¸µµ¤¤¬½Ð¤ë¡£

¤µ¤Æ¡¢ÇßÆÇ¼£ÎŤÎÏÀʸ¤ÎÃø¼Ô¤¬¤¤¤¦¸å¿Ê¹ñ¤ÎÃæ¤ËÆüËܤ¬Æþ¤Ã¤Æ¤¤¤ë¤Î¤«¤É¤¦¤«¤Ï¤½¤ì¤³¤½²Éʹ¤Ë¤·¤Æ¤ï¤«¤é¤Ê¤¤¤¬¡¢Ìô¤ÎÃÍÃʤ«¤é¸«¤ë¤È¥¢¥¸¥¹¥í¥Þ¥¤¥·¥ó¤¬¥Ú¥Ë¥·¥ê¥ó¤è¤ê¤â¥¯¥½¹â¤¤¤Î¤Ï»ö¼Â¤À¡£¤³¤ó¤Ê¥¯¥½¹â¤¤Ìô¤ÎÊý¤¬¸å¿Ê¹ñ¤Ç¤Ï¹¥¤Þ¤ì¤Æ»È¤ï¤ì¤ë¤Î¤À¤í¤¦¤«É®¼Ô¤Ë¤ÏÍý²òÉÔǽ¤Ç¤¢¤ë¡£

¥Ú¥Ë¥·¥ê¥ó£Ç¡§240Ëüñ°Ì¤Ç628.8±ß¡Ê262±ß/100Ëüñ°Ì´¹»»¡Ë
¥¢¥¸¥¹¥í¥Þ¥¤¥·¥ó¡§2£ç¤Ç2856±ß¡Ê357.30±ß/250mg¾û´¹»»¡Ë

Reference
¡¦´¶À÷¾É³°Íè¤Î»ö·ïÊí
¡¦Single-Dose Azithromycin versus Penicillin G Benzathine for the Treatment of Early Syphilis¡¡N Engl J Med 353: 1236-1244, 2005


¿Íµ¤blog¥é¥ó¥­¥ó¥°¤Ø
SHOCK
°ÊÁ°¡¢°¦ÃΤÎ˿ɱ¡¤Ë¼Â½¬¸«³Ø¤Ë¹Ô¤Ã¤¿ºÝ¡¢Æþ±¡Ãæ¤ËSHOCK¤Î´µ¼Ô¤µ¤ó¤¬¤¤¤¿¤Î¤À¤¬¡¢ÀèÀ¸¤¬¤¤¤È¤â¤¿¤ä¤¹¤¯Éû¿ÕÉÔÁ´¤ò´ÕÊ̤ˤ¢¤²¤Æ¤½¤Î¸åACTH¤À¤«Éû¿Õ¥Û¥ë¥â¥ó¤À¤«¡ÊLearning Issue¡Ë¤ÎÉé²Ù»î¸³¤ò¹Ô¤Ã¤Æ¿ÇÃǤ·¤Æ¤¤¤¿¤Î¤Ë¿´¤È¤­¤á¤¤¤¿¡£
¤³¤Î´µ¼Ô¤Ï²¿¤«¤Î´¶À÷¾É¤À¤Ã¤¿¤Î¤À¤¬Ëö¾¿·ì¤Ë¹¥»Àµå¤¬Àµ¾ï°Ê¾å¤Ç¤¢¤Ã¤¿¡£´¶À÷¾É¤ÎºÝ¤ÏËÜÍèStress Hormon¡Ê¥¹¥Æ¥í¥¤¥É¡©¡Ë¤¬¤Ç¤Æ¤¤¤ÆËö¾¿¤Ë¹¥»Àµå¤Ï¤¤¤Ê¤¤¤Ï¤º¤Ê¤Î¤Ë¤È¤¤¤¦¤¢¤¿¤ê¤«¤éµ¤¤Å¤¤¤¿¤È¤â¸À¤Ã¤Æ¤¤¤¿¡£

»ä¤¬º£Íý²ò¤·¤Æ¤¤¤ëSHOCK¤È¤¤¤¦¤â¤Î¤Ï¡¢·ì´É¤¬³«¤¤¤¿¤ê·ì±ÕÎ̤ϸº¤ë¤Ê¤ê¤·¤ÆÁ´¿È¤Î¡´ï¤¬É¬ÍפȤ¹¤ë·ìήÎ̤¬Íî¤Á¤ë¤³¤È¤Ë¤è¤ê²¿¤«¤È¤Þ¤º¤¤¤³¤È¤¬µ¯¤³¤ë¤È¤¤¤Ã¤¿¤¢¤¿¤ê¤À¡£
(Definition: Shock occurs when the arterial circulation is unable to keep up with the metabolic demands of the body)

¤³¤ÎÊÕ¤ê¤ÎÉÂÂÖÀ¸Íý¤«¤é¹¶¤á¤Æ¤ß¤Æ¤â¡¢¤½¤â¤½¤â¡ØSHOCK¤Î´ÕÊ̤ËÉû¿ÕÉÔÁ´¤¬¤¢¤ë¡Ù¤È¤¤¤¦¤³¤È¤òÃΤé¤Ê¤¤¤È¤É¤¦¤·¤è¤¦¤â¤Ê¤¤¡£

¤È¤¤¤¦¤³¤È¤Ç¥´¥í¤¬ÌòΩ¤Ä¡£

The Causes of SHOCK

Sepsis
Hypovolemic
Obstructive
Cardiac
Kooky

Kooky¡§Ì¯¤Á¤¯¤ê¤ó¤Ê

"Kooky" Disorder Leading to Shock ("DEAN")

Drug (primarily vasodilating drugs)
Endocrine (adrenal insufficiency or myxedema)
Anaphylaxis
Neurogenic (especially after spinal cord injury)

¤È¤¤¤¦¤³¤È¤ò¤È¤ê¤¢¤¨¤º³Ð¤¨¤Æ¤ª¤³¤¦¡£

Hypovolemic(trauma, GI bleeding, Hematoma, burns, pancreatitis, hyper osmolar states, vomiting, diarrhea)

Obstructive(cardiac tamponade, PE, tension pneumothorax, severe AS,and MS)

Cardiac(MI, DCM, Tachyarrhythmia,Bradyarrythmia, acute MR or AR, rupture of the septum or ventricular wall)


Reference
Saint-Frances Guide to Inpatient Medicine


¿Íµ¤blog¥é¥ó¥­¥ó¥°¤Ø
Spontaneous vs Tension
Saint¤Î4 killer chest pain¤Î°ì¤Ä¤Ë¤¢¤ë¡ØSpontaneous Pneumothorax¡Ù¤È¤¤¤¦¤â¤Î¤¬°ÊÁ°¤«¤éÎɤ¯¤ï¤«¤é¤Ê¤¤¡£

¤É¤³¤«¤Ç¤ß¤«¤±¤¿Ê̤ÎËܤǤÏkiller chest pain¤Î°ì¤Ä¤È¤·¤Æ¡ØTension Pneumothorax¡Ù¤¬¤¢¤²¤é¤ì¤Æ¤¤¤ë¡£

Harrison¤ò³«¤¤¤Æ¤ß¤ë¤È

Spontaneous¡¦¡¦¡¦Àè¹Ô¤¹¤ë¶»³Ô¤Î³°½ý̵¤·¤Ë¤ª¤³¤ë¤â¤Î¤Ç¸¶È¯À­¤È³ȯÀ­¤¬¤¢¤ë¡£¥Ö¥ì¥Ö¤ÎÇËÎö¤Ë¤è¤ê¤ª¤³¤ë¡£

Tension¡¦¡¦¡¦¸ÆµÛ¥µ¥¤¥¯¥ë¤òÄ̤¸¤Æ¶»Ëì¹ÐÆâ°µ¤¬ÍÛÀ­¤Îµ¤¶»

¤È¤¢¤ë¡£

¤É¤Á¤é¤«¤È¤¤¤¦¤ÈTension¤ÎÊý¤¬Ã×»àŪ¤Ç¤¢¤ë¤³¤È¤Ï¡Ø¶»¹ÐÆâ°µÍÛÀ­¤ÏÃ×»àŪ¤Ç¤¢¤ê¡¢´¹µ¤¤¬¹âÅ٤˾㳲¤µ¤ì¡¢ÍÛ°µ¤Ë¤è¤ê½Ä³Ö¤¬°µÇ÷¤µ¤ì¤ë¤¿¤áÀÅÌ®´ÔήÎ̤¬¸º¾¯¤·¿´Çï½ÐÎ̤θº¾¯¤¬¤ª¤³¤ë¡Ù¤Èµ­½Ò¤µ¤ì¤Æ¤¤¤ë¤³¤È¤«¤é¤â¿ä»¡¤µ¤ì¤ë¡£

¤Ç¤Ïµ¯¤³¤êÊý¤Ï¤É¤¦¤«¤È¤¤¤¦¤È¸¶È¯À­¤Îspontaneous¤Îµ¤¶»¤Ï¼ç¤ËµÊ±ì¼Ô¤Ëµ¯¤³¤ê¡¢Â³È¯À­¤Îµ¤¶»¤Ï¤Û¤È¤ó¤É¤¬COPD¤¬¸¶°ø¤Ç¤¢¤ë¡£¤Ç¡¢ÇÙ¼À´µ¤Î¤¢¤ë´µ¼Ô¤ÏÇÙ¤ÎͽÈ÷ǽ¤¬¤Ê¤¤¤¿¤á¡¢·ò¾ï¼Ô¤ËÈæ¤Ù¤ë¤ÈÃ×»àΨ¤¬¹â¤¤¤È¤¢¤ë¡£

°ìÊý¡¢Tension¤ÎÊý¤Ï¿´ÇÙÁÉÀ¸»þ¤Þ¤¿¤Ï¿Í¹©¸ÆµÛ»þ¤Ë¤ª¤³¤ë¡£

°Ê¾å¤Î¤³¤È¤«¤é¡¢Tension¤ÏͽÁÛ¤µ¤ì¤¦¤ëµ¤¶»¤Ç¤¢¤ê¡¢Spontaneous¤Ï´ðÁüÀ´µ¤ÎÍ­¤ê̵¤·¤Ë¤«¤«¤ï¤é¤º¡¢µ¿¤ï¤Ê¤¤¤È¶»ÄˤÎDDx¤Ë¤¢¤¬¤Ã¤Æ¤­Æñ¤¤¤È¤¤¤¦¤³¤È¤À¤í¤¦¤«¡£

¤È¤ê¤¢¤¨¤º¡¢¤³¤ÎÊÕ¤ê¤ÇÍý²ò¤·¤Æ¤ª¤¯¤³¤È¤È¤·¤è¤¦¡£


Pneumothorax
1.Primary Spontaneous Pneumothorax
2.Secondary Spontaneous Pneumothorax
3.Traumatic Pneumothorax
4.Tension Pneumothorax

Reference
Harrison 16th:Pneumothorax
Learning Issue
¡¦Éû¿ÕÉÔÁ´¤Î¿ÇÃÇË¡¡ÊSHOCK¤Îµ­»ö¡Ë

¡¦Ê¢¹ÐÆâÇ¿áç¤ÎEmpiric Therapy¤Ç¹¥µ¤À­¤ÎGNB¤È·ùµ¤À­¶Ý¤ò¥«¥Ð¡¼¤¹¤ë¥«¥ë¥Ð¥Ú¥Í¥à°Ê³°¤Î¹³¶ÝÌô¡£¡ÊMetronidazole¤ÎÅÀÅ©¤¬¤Ê¤¤¤Îµ­»ö¡Ë
¢ªÄ²ÆâºÙ¶Ý²Ê¤È·ùµ¤À­¶Ý¤ò¥«¥Ð¡¼